Novel Coronavirus (SARS-CoV-2/COVID-19)
U.S. hospitals will lose an estimated $54 billion in net income this year, even after federal relief funds, as higher labor and other expenses and sicker patients impact their financial health during the ongoing COVID-19 pandemic, according to a report by Kaufman, Hall & Associates released by…
A new analysis prepared by Kaufman, Hall & Associates, LLC and released by the American Hospital Association shows that higher expenses for labor, drugs and supplies as well as patients putting off care during the ongoing COVID-19 pandemic will continue to negatively impact the financial health…
America’s hospitals face significant, ongoing financial instability as the ravages of the COVID-19 pandemic continue to fester. Kaufman Hall projects hospitals nationwide will lose an estimated $54 billion in net income over the course of the year, even taking into account federal Coronavirus Aid,…
AHA Webinar on Strategies for Conserving Oxygen Amidst COVID-19 Surges
News coverage continues to show that many hospitals have been stretched beyond capacity during the COVID-19 pandemic. Each wave has brought incredible pressure on our health care workforce, and the physical and emotional exhaustion is leading to ever greater staff shortages at hospitals.
For nearly 20 grueling months, hospitals and health systems – and their steadfast front-line caregivers – have risen to the incredible challenges caused by COVID-19.
The Centers for Disease Control and Prevention revealed the comparative effectiveness of the three Food and Drug Administration-authorized COVID-19 vaccines, with Moderna’s vaccine deemed most effective at preventing hospitalizations.
The Centers for Disease Control and Prevention will invest $2.1 billion from the American Rescue Plan Act to help public health and other partners fight COVID-19 and other emerging infections in health care facilities, the Biden Administration announced.
The AHA has received a $1 million grant from the Centers for Disease Control and Prevention to continue for one year its efforts to encourage COVID-19 vaccine confidence in the hospital field, clinicians and the public.
A pair of peer-reviewed studies published in the New England Journal of Medicine are affirming the safety and effectiveness of Pfizer’s COVID-19 vaccine, first at six months following a completed, two-dose regimen, and then with boosters.